Daniel P. Walker

2.2k total citations · 1 hit paper
49 papers, 1.3k citations indexed

About

Daniel P. Walker is a scholar working on Pharmacology, Surgery and Molecular Biology. According to data from OpenAlex, Daniel P. Walker has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 14 papers in Surgery and 13 papers in Molecular Biology. Recurrent topics in Daniel P. Walker's work include Pancreatic function and diabetes (12 papers), Cannabis and Cannabinoid Research (10 papers) and Drug Transport and Resistance Mechanisms (8 papers). Daniel P. Walker is often cited by papers focused on Pancreatic function and diabetes (12 papers), Cannabis and Cannabinoid Research (10 papers) and Drug Transport and Resistance Mechanisms (8 papers). Daniel P. Walker collaborates with scholars based in Australia, Serbia and United States. Daniel P. Walker's co-authors include Jonathan Bauman, Amit S. Kalgutkar, Michael D. Aleo, David A. Price, Thomas A. Baillie, Antonia F. Stepan, Armin Mooranian, Hani Al‐Salami, Susbin Raj Wagle and Božica Kovačević and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Daniel P. Walker

49 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States

2011 494 citations Daniel P. Walker, Jonathan Bauman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel P. Walker Australia	16	510	267	247	174	164	49	1.3k
Sonia Lobo Planey United States	15	807 1.6×	297 1.1×	91 0.4×	281 1.6×	103 0.6×	26	1.7k
Stephen J. Ballaron United States	20	925 1.8×	268 1.0×	97 0.4×	91 0.5×	162 1.0×	26	1.8k
Behnam Kamalıdehghan Malaysia	25	774 1.5×	234 0.9×	162 0.7×	31 0.2×	119 0.7×	66	1.8k
Andrea Galmozzi United States	19	1.0k 2.0×	481 1.8×	45 0.2×	100 0.6×	103 0.6×	31	1.8k
Carmela Gnerre Switzerland	18	288 0.6×	374 1.4×	192 0.8×	81 0.5×	254 1.5×	39	1.1k
Zhiyang Zhao United States	22	675 1.3×	133 0.5×	283 1.1×	105 0.6×	162 1.0×	66	1.5k
Xiaoyu Chen China	24	973 1.9×	222 0.8×	180 0.7×	30 0.2×	89 0.5×	98	1.7k
Hiroyuki Miyachi Japan	28	1.1k 2.2×	665 2.5×	75 0.3×	91 0.5×	238 1.5×	93	2.1k
Fabrício Figueiró Brazil	26	755 1.5×	225 0.8×	66 0.3×	42 0.2×	122 0.7×	81	1.9k
Alessia Bertamino Italy	22	670 1.3×	469 1.8×	59 0.2×	85 0.5×	124 0.8×	83	1.5k

Countries citing papers authored by Daniel P. Walker

Since Specialization

Citations

This map shows the geographic impact of Daniel P. Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Walker more than expected).

Fields of papers citing papers by Daniel P. Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Walker. The network helps show where Daniel P. Walker may publish in the future.

Co-authorship network of co-authors of Daniel P. Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. Walker. A scholar is included among the top collaborators of Daniel P. Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. Walker. Daniel P. Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mooranian, Armin, Corina Mihaela Ionescu, Susbin Raj Wagle, et al.. (2022). Taurine Grafted Micro-Implants Improved Functions without Direct Dependency between Interleukin-6 and the Bile Acid Lithocholic Acid in Plasma. Biomedicines. 10(1). 111–111. 3 indexed citations

Mooranian, Armin, Corina Mihaela Ionescu, Daniel P. Walker, et al.. (2022). Single-Cellular Biological Effects of Cholesterol-Catabolic Bile Acid-Based Nano/Micro Capsules as Anti-Inflammatory Cell Protective Systems. Biomolecules. 12(1). 73–73. 14 indexed citations

Jones, Melissa, Corina Mihaela Ionescu, Daniel P. Walker, et al.. (2022). Biguanide Pharmaceutical Formulations and the Applications of Bile Acid-Based Nano Delivery in Chronic Medical Conditions. International Journal of Molecular Sciences. 23(2). 836–836. 8 indexed citations

Mooranian, Armin, Melissa Jones, Daniel P. Walker, et al.. (2022). 'In vitro' assessments of microencapsulated viable cells as a result of primary bile acid-encapsulated formulation for inflammatory disorders. SHILAP Revista de lepidopterología. 53(2). 103–115. 2 indexed citations

Mooranian, Armin, Melissa Jones, Daniel P. Walker, et al.. (2022). Pharmacological Dose-Effect Profiles of Various Concentrations of Humanised Primary Bile Acid in Encapsulated Cells. Nanomaterials. 12(4). 647–647. 8 indexed citations

Kovačević, Božica, Melissa Jones, Corina Mihaela Ionescu, et al.. (2022). The emerging role of bile acids as critical components in nanotechnology and bioengineering: Pharmacology, formulation optimizers and hydrogel-biomaterial applications. Biomaterials. 283. 121459–121459. 36 indexed citations

Mooranian, Armin, Corina Mihaela Ionescu, Daniel P. Walker, et al.. (2022). Reduced Cytokine Tumour Necrosis Factor by Pharmacological Intervention in a Preclinical Study. Biomolecules. 12(7). 877–877. 2 indexed citations

Walker, Daniel P., Melissa Jones, Corina Mihaela Ionescu, et al.. (2021). A Review on Recent Advancement on Age-Related Hearing Loss: The Applications of Nanotechnology, Drug Pharmacology, and Biotechnology. Pharmaceutics. 13(7). 1041–1041. 28 indexed citations

Mooranian, Armin, Melissa Jones, Corina Mihaela Ionescu, et al.. (2021). Artificial Cell Encapsulation for Biomaterials and Tissue Bio-Nanoengineering: History, Achievements, Limitations, and Future Work for Potential Clinical Applications and Transplantation. Journal of Functional Biomaterials. 12(4). 68–68. 10 indexed citations

10.

Mooranian, Armin, Corina Mihaela Ionescu, Susbin Raj Wagle, et al.. (2021). Polyelectrolytes Formulated with Primary Unconjugated Bile Acid Optimised Pharmacology of Bio-Engineered Implant. Pharmaceutics. 13(10). 1713–1713. 5 indexed citations

11.

Foster, Thomas S., Corina Mihaela Ionescu, Daniel P. Walker, et al.. (2021). Chemotherapy-Induced Hearing Loss: The Applications of Bio-Nanotechnologies and Bile Acid-Based Delivery Matrices. Therapeutic Delivery. 12(10). 723–737. 10 indexed citations

12.

Wagle, Susbin Raj, Božica Kovačević, Daniel P. Walker, et al.. (2020). Alginate-based drug oral targeting using bio-micro/nano encapsulation technologies. Expert Opinion on Drug Delivery. 17(10). 1361–1376. 50 indexed citations

13.

Wagle, Susbin Raj, Božica Kovačević, Daniel P. Walker, et al.. (2020). Pharmacological and Advanced Cell Respiration Effects, Enhanced by Toxic Human-Bile Nano-Pharmaceuticals of Probucol Cell-Targeting Formulations. Pharmaceutics. 12(8). 708–708. 31 indexed citations

14.

Lagojda, Andreas, et al.. (2020). Determination of Cotton as a Larval Feeding Source for Lepidopteran Moths Using a Derivative from Cotton Metabolites as a Marker by LC-MS/MS Method. Journal of Chemical Ecology. 46(10). 956–966. 1 indexed citations

15.

Walker, Daniel P., Natasha M. Kablaoui, Jeffrey A. Scholten, et al.. (2012). Synthesis and biological evaluation of substituted benzoxazoles as inhibitors of mPGES-1: Use of a conformation-based hypothesis to facilitate compound design. Bioorganic & Medicinal Chemistry Letters. 23(4). 1120–1126. 25 indexed citations

16.

Walker, Daniel P., Yvette M. Fobian, John R. Springer, et al.. (2012). Discovery and SAR of PF-4693627, a potent, selective and orally bioavailable mPGES-1 inhibitor for the potential treatment of inflammation. Bioorganic & Medicinal Chemistry Letters. 23(4). 1114–1119. 41 indexed citations

17.

Walker, Daniel P., Chungang Gu, Xiaojun Fang, et al.. (2010). Multiple Species Metabolism of PHA-568487, A Selective α7 Nicotinic Acetylcholine Receptor Agonist. Drug Metabolism Letters. 4(3). 163–172. 5 indexed citations

18.

Sun, Hao, Raman Sharma, Jonathan Bauman, et al.. (2009). Differences in CYP3A4 catalyzed bioactivation of 5-aminooxindole and 5-aminobenzsultam scaffolds in proline-rich tyrosine kinase 2 (PYK2) inhibitors: Retrospective analysis by CYP3A4 molecular docking, quantum chemical calculations and glutathione adduct detection using linear ion trap/orbitrap mass spectrometry. Bioorganic & Medicinal Chemistry Letters. 19(12). 3177–3182. 6 indexed citations

19.

Han, Seungil, Anil Mistry, Jeanne S. Chang, et al.. (2009). Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design. Journal of Biological Chemistry. 284(19). 13193–13201. 86 indexed citations

20.

Walker, Daniel P., Michael P. Zawistoski, Jiancheng Li, et al.. (2009). Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity. Bioorganic & Medicinal Chemistry Letters. 19(12). 3253–3258. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact